Navellier & Associates’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-985
Closed -$240K 329
2021
Q1
$240K Hold
985
0.04% 257
2020
Q4
$282K Sell
985
-104
-10% -$28.6K 0.05% 231
2020
Q3
$277K Buy
1,089
+13
+1% +$3.09K 0.06% 194
2020
Q2
$233K Sell
1,076
-35
-3% -$8.07K 0.06% 203
2020
Q1
$251K Sell
1,111
-144
-11% -$35.5K 0.06% 195
2019
Q4
$313K Sell
1,255
-134
-10% -$31.4K 0.05% 232
2019
Q3
$330K Sell
1,389
-110
-7% -$25.4K 0.05% 214
2019
Q2
$366K Sell
1,499
-48
-3% -$11.2K 0.06% 206
2019
Q1
$357K Sell
1,547
-53
-3% -$12K 0.06% 179
2018
Q4
$333K Sell
1,600
-99
-6% -$19.3K 0.06% 177
2018
Q3
$315K Sell
1,699
-61
-3% -$12.3K 0.04% 232
2018
Q2
$372K Sell
1,760
-26
-1% -$4.55K 0.05% 225
2018
Q1
$265K Sell
1,786
-46
-3% -$6.27K 0.04% 244
2017
Q4
$228K Sell
1,832
-36
-2% -$5.04K 0.04% 248
2017
Q3
$279K Sell
1,868
-339
-15% -$47.8K 0.05% 193
2017
Q2
$316K Sell
2,207
-370
-14% -$52.6K 0.05% 240
2017
Q1
$316K Buy
2,577
+217
+9% +$26.6K 0.05% 238
2016
Q4
$290K Buy
+2,360
New +$295K 0.05% 234

Other funds holding MLAB

Navellier & Associates's MLAB Position: Q2 2021 in Review

Navellier & Associates sold out of Mesa Laboratories (MLAB) in Q2 2021, closing a stake of 985 shares — an estimated $240K sold.

Navellier & Associates first reported a position in MLAB in Q4 2016 and held it in 18 quarters. The position peaked at $372K in Q2 2018. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2021.

  • Navellier & Associates reported no remaining Mesa Laboratories position as of Q2 2021 after selling out during the quarter.
  • Navellier & Associates sold 985 Mesa Laboratories shares in Q2 2021, an estimated $240K.
  • Navellier & Associates first reported a position in Mesa Laboratories in Q4 2016 and held it in 18 quarters.
  • Navellier & Associates's Mesa Laboratories position peaked at $372K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2021.

Based on Navellier & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.